MBXAX | QALAX | MBXAX / QALAX | |
Total Expense Ratio | 2.28 | 3.36 | 68% |
Annual Report Gross Expense Ratio | 2.28 | 3.36 | 68% |
Fund Existence | 10 years | 10 years | - |
Gain YTD | 3.971 | 12.182 | 33% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 10000 | 25% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.45B | 10.9M | 77,560% |
Annual Yield % from dividends | 1.62 | 0.80 | 203% |
Returns for 1 year | 5.04 | 8.13 | 62% |
Returns for 3 years | 7.78 | 18.04 | 43% |
Returns for 5 years | 48.59 | 17.10 | 284% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
AFDIX | 57.64 | 0.37 | +0.65% |
American Century Large Cap Equity Inv | |||
PREIX | 175.30 | 0.92 | +0.53% |
T. Rowe Price Equity Index 500 | |||
LRSTX | 20.62 | 0.09 | +0.44% |
Lord Abbett Small Cap Value R5 | |||
RYOIX | 76.94 | 0.30 | +0.39% |
Rydex Biotechnology Inv | |||
QRSAX | 43.82 | -0.02 | -0.05% |
FPA Queens Road Small Cap Value Advisor |